Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 379-388 , May 2009

Comparison of conventional and novel PET tracers for imaging mesothelioma in nude mice with subcutaneous and intrapleural xenografts

  • Atsushi B. Tsuji

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
  • ,
  • Chizuru Sogawa

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
  • ,
  • Aya Sugyo

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
  • ,
  • Hitomi Sudo

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan
  • ,
  • Jun Toyohara

      Affiliations

    • Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, 206-8670, Japan
  • ,
  • Mitsuru Koizumi

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
  • ,
  • Masaaki Abe

      Affiliations

    • Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan
  • ,
  • Okio Hino

      Affiliations

    • Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan
  • ,
  • Yoshi-nobu Harada

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
  • ,
  • Takako Furukawa

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
  • ,
  • Kazutoshi Suzuki

      Affiliations

    • Molecular Probe Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
  • ,
  • Tsuneo Saga

      Affiliations

    • Diagnostic Imaging Group, Molecular Imaging Center, National Institute of Radiological Sciences, Chiba 263-8555, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 43 206 3421; fax: +81 43 206 0818.

Received 27 November 2008 ,Revised 27 January 2009 ,Accepted 31 January 2009.

References 

  1. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591–1603
  2. Tsiouris A, Walesby RK. Malignant pleural mesothelioma: current concepts in treatment. Nat Clin Pract Oncol. 2007;4:344–352
  3. Kanazawa N, Ioka A, Tsukuma H, Ajiki W, Oshima A. Incidence and survival of mesothelioma in Osaka, Japan. Jpn J Clin Oncol. 2006;36:254–257
  4. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer. 1999;79:666–672
  5. Juweid ME, Cheson BD. Positron-emission tomography and assessment of cancer therapy. N Engl J Med. 2006;354:496–507
  6. Benard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest. 1998;114:713–722
  7. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61–77
  8. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25:1357–1368
  9. van Waarde A, Cobben DC, Suurmeijer AJ, Maas B, Vaalburg W, de Vries EF, et al. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med. 2004;45:695–700
  10. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334–1336
  11. Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G, et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med. 2003;44:1426–1431
  12. Toyohara J, Okada M, Toramatsu C, Suzuki K, Irie T. Feasibility studies of 4′-[methyl-(11)C]thiothymidine as a tumor proliferation imaging agent in mice. Nucl Med Biol. 2008;35:67–74
  13. Toyohara J, Kumata K, Fukushi K, Irie T, Suzuki K. Evaluation of 4′-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging. J Nucl Med. 2006;47:1717–1722
  14. Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S, et al. Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci. 2006;97:387–394
  15. Martarelli D, Catalano A, Procopio A, Orecchia S, Libener R, Santoni G. Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis. BMC Cancer. 2006;6:130
  16. Martin SJ, Eisenbarth JA, Wagner-Utermann U, Mier W, Henze M, Pritzkow H, et al. A new precursor for the radiosynthesis of [18F]FLT. Nucl Med Biol. 2002;29:263–273
  17. Toyohara J, Hayashi A, Sato M, Tanaka H, Haraguchi K, Yoshimura Y, et al. Rationale of 5-(125)I-iodo-4′-thio-2′-deoxyuridine as a potential iodinated proliferation marker. J Nucl Med. 2002;43:1218–1226
  18. Hino O, Shiomi K, Maeda M. Diagnostic biomarker of asbestos-related mesothelioma: example of translational research. Cancer Sci. 2007;98:1147–1151
  19. Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, et al. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med. 2006;47:999–1006
  20. Dittmann H, Dohmen BM, Paulsen F, Eichhorn K, Eschmann SM, Horger M, et al. [18F]FLT PET for diagnosis and staging of thoracic tumours. Eur J Nucl Med Mol Imaging. 2003;30:1407–1412
  21. Paproski RJ, Ng AM, Yao SY, Graham K, Young JD, Cass CE. The role of human nucleoside transporters in uptake of 3′-deoxy-3′-fluorothymidine. Mol Pharmacol. 2008;74:1372–1380

PII: S0969-8051(09)00041-9

doi: 10.1016/j.nucmedbio.2009.01.018

Nuclear Medicine and Biology
Volume 36, Issue 4 , Pages 379-388 , May 2009